Steve Damment
Founder presso Aluztura Bio Ltd.
Profilo
Founder of Aluztura Bio Ltd., Steve Damment is Chief Science Officer at Aluztura Bio Ltd.
In his past career he held the position of Executive Vice President-Research & Development at Midatech Pharma Plc, Senior Vice President-Biosciences at GlaxoSmithKline Plc and Senior Vice President-Biosciences at Shire Plc.
He received an undergraduate degree from The University of Liverpool.
Posizioni attive di Steve Damment
Società | Posizione | Inizio |
---|---|---|
Aluztura Bio Ltd. | Founder | 01/01/2014 |
Precedenti posizioni note di Steve Damment
Società | Posizione | Fine |
---|---|---|
BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 30/09/2021 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01/12/2013 |
GSK PLC | Corporate Officer/Principal | 01/12/1999 |
Formazione di Steve Damment
The University of Liverpool | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GSK PLC | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Aziende private | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aluztura Bio Ltd. |